1. Home
  2. IPSC vs AWRE Comparison

IPSC vs AWRE Comparison

Compare IPSC & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • AWRE
  • Stock Information
  • Founded
  • IPSC 2019
  • AWRE 1986
  • Country
  • IPSC United States
  • AWRE United States
  • Employees
  • IPSC N/A
  • AWRE N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • IPSC Health Care
  • AWRE Technology
  • Exchange
  • IPSC Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • IPSC 43.6M
  • AWRE 58.6M
  • IPO Year
  • IPSC 2021
  • AWRE 1996
  • Fundamental
  • Price
  • IPSC $0.48
  • AWRE $2.62
  • Analyst Decision
  • IPSC Strong Buy
  • AWRE
  • Analyst Count
  • IPSC 5
  • AWRE 0
  • Target Price
  • IPSC $3.33
  • AWRE N/A
  • AVG Volume (30 Days)
  • IPSC 503.4K
  • AWRE 53.6K
  • Earning Date
  • IPSC 11-04-2025
  • AWRE 10-29-2025
  • Dividend Yield
  • IPSC N/A
  • AWRE N/A
  • EPS Growth
  • IPSC N/A
  • AWRE N/A
  • EPS
  • IPSC N/A
  • AWRE N/A
  • Revenue
  • IPSC $114,128,000.00
  • AWRE $16,146,999.00
  • Revenue This Year
  • IPSC $1,589.94
  • AWRE N/A
  • Revenue Next Year
  • IPSC N/A
  • AWRE N/A
  • P/E Ratio
  • IPSC N/A
  • AWRE N/A
  • Revenue Growth
  • IPSC 5491.77
  • AWRE N/A
  • 52 Week Low
  • IPSC $0.34
  • AWRE $1.35
  • 52 Week High
  • IPSC $1.86
  • AWRE $2.95
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 40.86
  • AWRE 53.61
  • Support Level
  • IPSC $0.48
  • AWRE $2.66
  • Resistance Level
  • IPSC $0.51
  • AWRE $2.84
  • Average True Range (ATR)
  • IPSC 0.02
  • AWRE 0.18
  • MACD
  • IPSC 0.00
  • AWRE -0.01
  • Stochastic Oscillator
  • IPSC 32.93
  • AWRE 57.35

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: